Description: Tristel Plc is a United Kingdom-based manufacturer of infection prevention and contamination control products. The Company's technology is a chlorine dioxide formulation. The Company operates through three segments: Human Healthcare, Animal Healthcare and Contamination Control. The Human Healthcare segment is engaged in the manufacture, development and sale of infection control and hygiene products, which include products that are used primarily for infection control in hospitals. The segments products are marketed under the brand, Tristel. The Animal Healthcare segment relates to manufacture and sale of disinfection and cleaning products into veterinary and animal welfare sectors. The segments products are marketed under the brand, Anistel. The Contamination Control segment addresses the pharmaceutical and personal care product manufacturing industries. The segments products are marketed under the brand, Crystel. Its manufacturing facility is located in Newmarket, Cambridgeshire.
Home Page: www.tristel.com
TSTL Technical Analysis
Lynx Business Park
Newmarket,
CB8 7NY
United Kingdom
Phone:
44 16 3872 1500
Officers
| Name | Title |
|---|---|
| Mr. Paul C. Swinney | CEO & Exec. Director |
| Ms. Elizabeth A. Dixon | CFO & Exec. Director |
| Mr. Bart Victor Margaretha Leemans | Exec. Director |
| Ms. Heidi A. Allard | UK Fin. Director, Global Financial Controller & Company Sec. |
Exchange: LSE
Country: UK : United Kingdom
Currency: Pence sterling (p)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Supplies |
| Forward PE: | 33.67 |
|---|---|
| Trailing PE: | 190 |
| Price-to-Book MRQ: | 5.8668 |
| Price-to-Sales TTM: | 5.9181 |
| IPO Date: | 2005-06-01 |
| Fiscal Year End: | June |
| Full Time Employees: | 199 |